951.9500 14.20 (1.51%)
NSE Sep 10, 2025 15:56 PM
Volume: 146.7K
 

ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 33% YoY to | 863 crore (I-direct estimate: | 817 crore) on account of 40% YoY growth in domestic formulations to | 331 crore (I-direct estimate: | 327 crore), up 79% YoY in international (ex-US) business to | 126 crore (I-direct estimate: | 69 crore) and 38.5% YoY growth in API segment to | 180 crore EBITDA margins improved 186 bps YoY to 17.5% but came in lowerthan I-direct estimate of 20.0% mainly due higher other expenditure. EBITDA grew 48.8% YoY to | 151 crore...
Alembic Pharmaceuticals Ltd. is trading below all available SMAs
More from Alembic Pharmaceuticals Ltd.
Recommended